Your browser doesn't support javascript.
loading
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.
Wang, Wei; Nishioka, Yasuhiko; Ozaki, Shuji; Jalili, Ali; Abe, Shinji; Kakiuchi, Soji; Kishuku, Masatoshi; Minakuchi, Kazuo; Matsumoto, Toshio; Sone, Saburo.
Affiliation
  • Wang W; Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto-cho, Tokushima, Japan.
Cancer Immunol Immunother ; 58(6): 967-76, 2009 Jun.
Article in En | MEDLINE | ID: mdl-18979097

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Antigens, CD / Immunotherapy / Lung Neoplasms / Antibody-Dependent Cell Cytotoxicity Limits: Animals / Female / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2009 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Antigens, CD / Immunotherapy / Lung Neoplasms / Antibody-Dependent Cell Cytotoxicity Limits: Animals / Female / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2009 Type: Article Affiliation country: Japan